Bone Marrow Transplantation

Papers
(The H4-Index of Bone Marrow Transplantation is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
When is a chimaera not a chimaera?291
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P725-P741)98
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards77
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study69
OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)66
Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen64
Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes62
Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study56
Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency56
Randomized phase 2 study of digital life coaching during transplantation for myeloma53
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma50
Prognostic impact of histopathologic features including histological grading and immunohistochemistry-positive cell counts in cytomegalovirus-gastrointestinal disease after allogeneic hematopoietic ce48
The effect of posttransplant cyclophosphamide on ocular graft-versus-host disease45
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the 41
Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey38
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia37
The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Poster Session (P919-P930)37
T cell redirection as a new standard of care for relapsed multiple myeloma: impact on inpatient capacity, financial burden and infrastructural requirements in Germany36
CD28-costimulated CD19 CAR-T cells for pediatric mature non-Hodgkin B-cell lymphoma35
Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy34
DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma32
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact31
The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation31
Role of extracorporeal photopheresis in the management of acute and chronic graft versus disease: current status29
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China29
Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin28
Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients28
Health-related quality of life in pediatric patients with β-thalassemia major after hematopoietic stem cell transplantation27
0.046770095825195